Sedation drug comparison for high-risk ERCP patients
Treatments studied
Part of Digestive system clinical trials.
This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 90 years old.
- Your body mass index is between 18 and 30.
- You have significant health issues (classified as ASA class III or IV).
- You do not have severe heart, lung, bleeding, liver, or kidney problems.
- You are not having an emergency procedure.
- You do not have severe blood pressure problems or irregular heart rhythms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial compares two sedative medications, remimazolam and propofol, to see which works better and is safer for people having a colonoscopy to remove polyps. It could help choose a sedation option with fewer side effects.
This trial tests whether remimazolam, a newer sedative, works as well as midazolam (a common sedative) for keeping patients comfortable during endoscopy procedures that examine the stomach and pancreas. The study aims to see which medication has fewer side effects.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
Hear when a new the Severity and Duration of Intraoperative Hypotension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.